Investigating Calcium Homeostasis During a Key Mitochondrial Stress Pathway
研究关键线粒体应激途径中的钙稳态
基本信息
- 批准号:10553100
- 负责人:
- 金额:$ 4.51万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-01-16 至 2024-01-15
- 项目状态:已结题
- 来源:
- 关键词:Alzheimer&aposs DiseaseApoptosisBiological AssayCRISPR screenCalciumCalcium SignalingCalcium ionCell LineCell NucleusCellsCellular StressCellular biologyChimeric ProteinsClustered Regularly Interspaced Short Palindromic RepeatsComputer softwareCytosolDataDiseaseEducational process of instructingEnsureEventExhibitsFacultyFinancial costFundingGenesGeneticGenetic TranscriptionGoalsHealthHeat shock proteinsHereditary Spastic ParaplegiaHomeostasisHumanImage AnalysisImaging TechniquesImmunityInner mitochondrial membraneIonsKnock-outKnowledgeLaser Scanning Confocal MicroscopyLeadLinkMediatingMessenger RNAMetabolismMitochondriaMitochondrial MatrixMitochondrial ProteinsMolecularMolecular ChaperonesMutationNeurodegenerative DisordersNuclearParkinson DiseasePathway interactionsPhosphotransferasesPlayPreventionProteinsRegulationReporterResearchRoleSignal PathwaySignal TransductionStressTestingTrainingTranscriptional RegulationTranslationsUniversitiesWashingtonWestern BlottingWorkbiological adaptation to stresscalcium uniportercandidate identificationcareercomputerized data processingexperimental studygenome-wideinsightknock-downlive cell imaginglive cell microscopymicroscopic imagingmisfolded proteinmitochondrial metabolismnew therapeutic targetnoveloptical imagingpharmacologicprogramsprotein degradationproteostasisresponseskillssuccesstherapeutic targettooltranscription factortreatment strategyuptake
项目摘要
PROJECT SUMMARY
Mitochondria are central to cellular metabolism, signaling, protein homeostasis, immunity, and apoptosis. One
of the ways by which mitochondria respond effectively to changing mitochondrial and cellular needs is with
calcium signaling. Ca2+ ions enter the mitochondrial matrix through a protein channel called the mitochondrial
calcium uniporter (MCU) that resides on the inner membrane of the mitochondria. Altered MCU-mediated
mitochondrial calcium signaling is involved in a variety of human neurodegenerative diseases including
Parkinson's disease, Alzheimer's disease, and hereditary spastic paraplegia. Furthermore, these same diseases
have been shown to exhibit the hallmarks of mitochondrial protein stress, including elevated protein levels of
mitochondrial chaperones. Mitochondrial protein stress can be caused by misfolded or unfolded proteins
accumulating within the mitochondria. Preliminary studies in the Sancak Lab suggest that MCU-mediated
calcium signaling plays a critical role in facilitating the mitochondrial protein stress response. Data showing
increased MCU mRNA and protein during mitochondrial protein stress suggests that MCU is upregulated as part
of a mitochondrial protein stress response. Even more intriguingly, relative to WT and MCU rescue cell lines,
MCU knockout cells have lower baseline levels of mitochondrial chaperones and ATF4, a transcription factor
central to cellular stress responses. Furthermore, when mitochondrial protein stress is induced, the mRNA levels
of ATF4 and these chaperones increase much less than in WT or rescue cells. The central hypothesis of this
proposal is that altered MCU regulation and calcium signaling comprise a heretofore uncharacterized pathway
that regulates transcription in response to mitochondrial protein stress. Aim 1 will offer new insight about the
molecular mechanisms regulating the transcription, translation and protein stability of MCU. The functional
studies of Aim 2 will reveal how mitochondrial protein stress alters calcium signaling and transcription. Successful
completion of this proposal will advance the field by identifying novel players in the poorly understood
mitochondria-to-nuclear signaling pathway. These findings will also uncover a new function for mitochondrial
calcium signaling in the regulation of a transcriptional response central to the mitochondrial protein stress
response, and will reveal potential therapeutic targets for the treatment of neurodegenerative disease.
Completion of Aim 1 will provide valuable training in pairing gene editing with pharmacological tools to dissect
the function and regulation of MCU, a protein with great disease relevance. Completion of Aim 2 will provide
training in using laser-scanning confocal microscopy and live imaging techniques to study mitochondrial stress.
The University of Washington is very well funded and well equipped. Its top tier faculty, staff, and technicians,
and variety of state-of-the-art facilities will ensure the success of this proposed work.
项目总结
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Melissa Jane Macewen其他文献
Melissa Jane Macewen的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Melissa Jane Macewen', 18)}}的其他基金
Investigating Calcium Homeostasis During a Key Mitochondrial Stress Pathway
研究关键线粒体应激途径中的钙稳态
- 批准号:
10386304 - 财政年份:2022
- 资助金额:
$ 4.51万 - 项目类别:
相似国自然基金
新型F-18标记香豆素衍生物PET探针的研制及靶向Alzheimer's Disease 斑块显像研究
- 批准号:81000622
- 批准年份:2010
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
阿尔茨海默病(Alzheimer's disease,AD)动物模型构建的分子机理研究
- 批准号:31060293
- 批准年份:2010
- 资助金额:26.0 万元
- 项目类别:地区科学基金项目
跨膜转运蛋白21(TMP21)对引起阿尔茨海默病(Alzheimer'S Disease)的γ分泌酶的作用研究
- 批准号:30960334
- 批准年份:2009
- 资助金额:22.0 万元
- 项目类别:地区科学基金项目
相似海外基金
Pathophysiological mechanisms of hypoperfusion in mouse models of Alzheimer?s disease and small vessel disease
阿尔茨海默病和小血管疾病小鼠模型低灌注的病理生理机制
- 批准号:
10657993 - 财政年份:2023
- 资助金额:
$ 4.51万 - 项目类别:
Social Connectedness and Communication in Parents with Huntington''s Disease and their Offspring: Associations with Psychological and Disease Progression
患有亨廷顿病的父母及其后代的社会联系和沟通:与心理和疾病进展的关联
- 批准号:
10381163 - 财政年份:2022
- 资助金额:
$ 4.51万 - 项目类别:
The Role of Menopause-Driven DNA Damage and Epigenetic Dysregulation in Alzheimer s Disease
更年期驱动的 DNA 损伤和表观遗传失调在阿尔茨海默病中的作用
- 批准号:
10531959 - 财政年份:2022
- 资助金额:
$ 4.51万 - 项目类别:
The Role of Menopause-Driven DNA Damage and Epigenetic Dysregulation in Alzheimer s Disease
更年期驱动的 DNA 损伤和表观遗传失调在阿尔茨海默病中的作用
- 批准号:
10700991 - 财政年份:2022
- 资助金额:
$ 4.51万 - 项目类别:
Interneurons as early drivers of Huntington´s disease progression
中间神经元是亨廷顿病进展的早期驱动因素
- 批准号:
10518582 - 财政年份:2022
- 资助金额:
$ 4.51万 - 项目类别:
Interneurons as Early Drivers of Huntington´s Disease Progression
中间神经元是亨廷顿病进展的早期驱动因素
- 批准号:
10672973 - 财政年份:2022
- 资助金额:
$ 4.51万 - 项目类别:
Social Connectedness and Communication in Parents with Huntington''s Disease and their Offspring: Associations with Psychological and Disease Progression
患有亨廷顿病的父母及其后代的社会联系和沟通:与心理和疾病进展的关联
- 批准号:
10585925 - 财政年份:2022
- 资助金额:
$ 4.51万 - 项目类别:
Oligodendrocyte heterogeneity in Alzheimer' s disease
阿尔茨海默病中的少突胶质细胞异质性
- 批准号:
10180000 - 财政年份:2021
- 资助金额:
$ 4.51万 - 项目类别:
Serum proteome analysis of Alzheimer´s disease in a population-based longitudinal cohort study - the AGES Reykjavik study
基于人群的纵向队列研究中阿尔茨海默病的血清蛋白质组分析 - AGES 雷克雅未克研究
- 批准号:
10049426 - 财政年份:2021
- 资助金额:
$ 4.51万 - 项目类别:
Repurposing drugs for Alzheimer´s disease using a reverse translational approach
使用逆翻译方法重新利用治疗阿尔茨海默病的药物
- 批准号:
10295809 - 财政年份:2021
- 资助金额:
$ 4.51万 - 项目类别:














{{item.name}}会员




